Humana (HUM) Slid as Medicare Advantage Rate Fell Short of Expectations

In its first-quarter 2026 capitalist letter, Artisan Value Fund highlighted stocks similar Humana Inc. (NYSE:HUM). Humana Inc. (NYSE:HUM) is an American security institution that provides aesculapian and specialty security products. On May 22, 2026, Humana Inc. (NYSE:HUM) closed astatine $307.95 per share. One-month instrumentality of Humana Inc. (NYSE:HUM) was 37.71%, and its shares gained 36.91% implicit the past 52 weeks. Humana Inc. (NYSE:HUM) has a marketplace capitalization of $36.97 billion.

Artisan Value Fund stated the pursuing regarding Humana Inc. (NYSE:HUM) successful its Q1 2026 capitalist letter:

"Among the portfolio’s biggest decliners were Salesforce, Accenture, Humana Inc. (NYSE:HUM) and PayPal Holdings, each of which dropped by 20% oregon much during the quarter. Managed attraction stocks, including Humana, besides declined during the quarter. The assemblage came nether unit aft the Centers for Medicare & Medicaid Services (CMS) released a preliminary 2027 Medicare Advantage complaint update that was importantly beneath expectations. The projected summation of conscionable 0.09% was fundamentally level compared with capitalist expectations of 4% to 6%. While last rates are often revised higher, the announcement was a meaningful disappointment and adds uncertainty to Humana’s multiyear turnaround. More broadly, the managed attraction manufacture continues to look higher aesculapian costs driven by elevated utilization. Humana is besides dealing with little prime ratings nether the Medicare Stars program, which could trim bonus payments implicit the adjacent respective years. Although the banal appears inexpensive pursuing its caller decline, we chose to exit the presumption fixed the company’s dense vulnerability to Medicare Advantage and the hazard that argumentation and execution challenges could hold a betterment successful margins and earnings."